These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 991807)

  • 21. [Comparison of the therapeutic effect of triperidol with perphenazine in schizophrenia].
    Náhunek K; Hádlik J; Svestka J; Rodová A; Vanýsek J
    Cesk Psychiatr; 1969 Oct; 65(5):281-9. PubMed ID: 5363280
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of schizophrenics with perphenazine enanthate].
    Madsen A; Sorensen J
    Nord Psykiatr Tidsskr; 1971; 25(5):475-8. PubMed ID: 5144306
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of the therapeutic results of clothiapin and perphenazine in schizophrenia.
    Rodová A; Náhunek K; Svestka J
    Act Nerv Super (Praha); 1971; 13(3):171-3. PubMed ID: 4939829
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experiences with perphenazine enanthate].
    Rafter B
    Nord Psykiatr Tidsskr; 1971; 25(4):371-4. PubMed ID: 5154124
    [No Abstract]   [Full Text] [Related]  

  • 25. A double-blind comparison of haloperidol with perphenazine in acute psychiatric episodes.
    Fitzgerald CH
    Curr Ther Res Clin Exp; 1969 Aug; 11(8):515-9. PubMed ID: 4979702
    [No Abstract]   [Full Text] [Related]  

  • 26. Urinary excretion of perphenazine and its sulfoxide during administration in oral and long-acting injectable form.
    van Kempen GM
    Psychopharmacologia; 1971; 21(3):283-6. PubMed ID: 5095416
    [No Abstract]   [Full Text] [Related]  

  • 27. The CYP2D6 genotype predicts the oral clearance of the neuroleptic agents perphenazine and zuclopenthixol.
    Jerling M; Dahl ML; Aberg-Wistedt A; Liljenberg B; Landell NE; Bertilsson L; Sjöqvist F
    Clin Pharmacol Ther; 1996 Apr; 59(4):423-8. PubMed ID: 8612387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy control of perphenazine. 2. Clinical aspects].
    Kjeldsen CS; Larsen NE; Kragh-Sørensen P; Andersen E; Brøsen K; Gerholt F; Glue P; Hørder M; Klitgaard NA; Krarup G
    Ugeskr Laeger; 1991 Aug; 153(34):2339-43. PubMed ID: 1897043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of choreic movements with perphenazine.
    Fahn S
    Dis Nerv Syst; 1972 Oct; 33(10):653-8. PubMed ID: 4265163
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of anxiety and depression. A double-blind study of a perphenazine and amitriptyline in combination.
    Davis WG
    Rocky Mt Med J; 1967 Nov; 64(11):73-6. PubMed ID: 6062673
    [No Abstract]   [Full Text] [Related]  

  • 31. The treatment of anxiety and depression in general practice using an amitriptyline-perphenazine preparation.
    Gomez JR; Gomez G
    Br J Clin Pract; 1968 Mar; 22(3):105-9. PubMed ID: 5639425
    [No Abstract]   [Full Text] [Related]  

  • 32. [Trial treatment of reactive and neurotic depressions with an association of amitriptyline and perphenazine].
    Chateau R
    Therapeutique; 1972 Jan; 48(1):67-9. PubMed ID: 5046374
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of long-acting neuroleptics in impala (Aepyceros melampus).
    Gandini GC; Ebedes H; Burroughs RE
    J S Afr Vet Assoc; 1989 Dec; 60(4):206-7. PubMed ID: 2577291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled cross-over comparison of isofloxythepin and perphenazine in the treatment of schizophrenic psychoses.
    Svestka J; Náhunek K; Cesková E; Rysánek R; Balsíková J
    Act Nerv Super (Praha); 1989 Apr; 31(1):32-4. PubMed ID: 2571218
    [No Abstract]   [Full Text] [Related]  

  • 35. Controlled cross-over comparison of carbamazepine with perphenazine in schizophrenic psychoses.
    Svestka J; Cesková E; Rysánek R; Náhunek K
    Act Nerv Super (Praha); 1989 Dec; 31(4):276-7. PubMed ID: 2576922
    [No Abstract]   [Full Text] [Related]  

  • 36. [A recent clinical trial of perphenazine].
    Scotto JC
    Psychopharmacologie; 1971; ():83-5. PubMed ID: 5162010
    [No Abstract]   [Full Text] [Related]  

  • 37. [Results of treatment of schizophrenic and schizoaffective patients with sulpiride (Eglonyl Alkaloid) in comparison with perphenazine (Perfenazin Spofa)].
    Svestka J; Rysánek R; Náhunek K; Cesková E
    Cesk Psychiatr; 1990 Jun; 86(3):145-56. PubMed ID: 2225184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the short-term therapeutic effect of oxyprothepine and perphenazine in schizophrenic patients. A controlled study.
    Svestka J; Rodovà A; Nàhunek K
    Act Nerv Super (Praha); 1973 May; 15(2):103-4. PubMed ID: 4591602
    [No Abstract]   [Full Text] [Related]  

  • 39. [Controlled studies with thiothixene and perphenazine in schizophrenic psychoses].
    Hádlík J; Svestka J; Náhunek K; Rodová A
    Act Nerv Super (Praha); 1970 Jan; 12(1):60-1. PubMed ID: 4907392
    [No Abstract]   [Full Text] [Related]  

  • 40. [Further observations on the effects of the treatment with amitriptyline and perphenazine in essential headache].
    Pisani RA; Lazzari R; Franzese A; Arzilli A
    Clin Ter; 1987 Sep; 122(5):345-50. PubMed ID: 2972451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.